Fox Run Management L.L.C. grew its stake in shares of Perrigo Company plc (NYSE:PRGO – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,381 shares of the company’s stock after acquiring an additional 548 shares during the quarter. Fox Run Management L.L.C.’s holdings in Perrigo were worth $293,000 at the end of the most recent quarter.
Several other large investors have also modified their holdings of the stock. Versant Capital Management Inc acquired a new position in shares of Perrigo in the 4th quarter valued at $45,000. GAMMA Investing LLC boosted its holdings in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock valued at $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC increased its stake in Perrigo by 97.8% during the fourth quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company’s stock worth $108,000 after acquiring an additional 2,084 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Perrigo in the 4th quarter worth about $149,000. 95.91% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In related news, EVP Ronald Craig Janish sold 7,800 shares of the company’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total transaction of $214,032.00. Following the sale, the executive vice president now directly owns 33,666 shares of the company’s stock, valued at approximately $923,795.04. This represents a 18.81 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Company insiders own 0.70% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Research Report on Perrigo
Perrigo Stock Performance
Perrigo stock opened at $27.74 on Friday. The firm has a market capitalization of $3.79 billion, a PE ratio of -23.71 and a beta of 0.48. Perrigo Company plc has a one year low of $23.14 and a one year high of $33.46. The stock’s 50 day moving average price is $26.03 and its 200 day moving average price is $26.16. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56.
Perrigo (NYSE:PRGO – Get Free Report) last released its quarterly earnings results on Thursday, February 27th. The company reported $0.93 EPS for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion for the quarter, compared to analysts’ expectations of $1.20 billion. As a group, sell-side analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.
Perrigo Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th were given a $0.29 dividend. The ex-dividend date was Friday, March 7th. This represents a $1.16 annualized dividend and a dividend yield of 4.18%. This is an increase from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s payout ratio is presently -92.80%.
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories
- Five stocks we like better than Perrigo
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to SellĀ
- How to Use the MarketBeat Excel Dividend Calculator
- Top 3 Beverage Stocks Pouring Out Profits
- Trading Stocks: RSI and Why it’s Useful
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding PRGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Perrigo Company plc (NYSE:PRGO – Free Report).
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.